Management of locally advanced prostate cancer 1. Staging, natural history, and results of radical surgery

World Journal of Urology

Volumn 18, Issue 3, 2000, Pages 194-203

  Van Ouden, Dies Den ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; CANCER STAGING; DISEASE COURSE; HUMAN; LYMPH NODE METASTASIS; MALE; MORTALITY; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

DISEASE PROGRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034207953     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003459900102     Document Type: Article

References (79)

1. Adolfsson J (1993) Deferred treatment of low-grade stage T3 prostate cancer without distant métastases. J Urol 149' 3-46 329
2. Andriole GL, Coplen DE, Mikkelsen DJ, Catalona WJ (1989) Sonographic and pathological staging of patients with clinically localised prostate cancer. J Urol 142: 1259 1261
3. Anscher MS Prosnitz LR (1987) Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138: 1407-1412
4. Aus G, Hugosson J, Norlen L (1995) Long-term survival and mortality in prostate cancer treated with non-curative intent. J Urol 154: 460-465
5. Bluestein DL, Bostwick DG, Bergstrahl EJ, Oesterling JE (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315
6. Bosch JHLR, Schröder FH (1986) Current problems in staging and grading prostatic carcinoma with special reference to T3 carcinoma of the prostate. World J Urol 4: 141-146
7. Bosch RJLH, Kurth KH, Schröder FH (1987) Surgical treatment of locally advanced (T3) prostatic carcinoma: early results. J Urol 138: 816-822
8. Byar DP, Corle DK (1981) VACURG randomised trials of radical prostatectomy for stage I and II prostate cancer. Urology 17 [Suppl]: 7-11
9. Catalona WJ, Bigg SW (1990) Nerve sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 143: 538-544
10. Catalona WJ, Smith DS (1994) 5 year tumor recurrence rates after radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837-1842
11. Catalona WJ, Miller DR, Kavoussi LR (1988) Intermediateterm survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 140: 540-543
12. Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954
13. Chodak GW, Thisted RA, Gerber GS, Johansson JE. Adolfsson J, Jones GW. Chisholm GD, Moskovitz CBEB, Livne PM, Warner J (1994) Results of conservative management of clinically localised prostate cancer. N Engl J Med 330: 242-248
14. Davidson PJT, Hop W, Kurth KH, Fossa SD, Waehre H, Schröder FH, the EORTC Genito-Urinary Group (1995) Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage TO to T4, Nl to N3. MO. Dl). J Urol 154: 2118-2122
15. Davidson PJT, Ouden D van den, Schröder FH (1996) Radical prostatectomy: prospective assessment of mortality and morbidity. Eur Urol 29: 168-173
16. Eisbruch A, Ferez ÇA, Roessler EH, Lockett MA (1994) Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 73: 384-387
17. Elder JC, Jewett HJ, Walsh PC (1982) Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127: 704-706
18. Epstein JE ( 1990) Evaluation of radical prostatectomy capsular margins of resection: the significance of margins designated as negative, closely approaching and positive. Am J Surg Pathol 14: 626-632
19. Epstein JI, Carmichael MJ, Pizov G, Walsh PC (1993) Influence of capsule penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J Urol 150: 135-141
20. Ereth JT, Miller JI, McBeath RB, Hansen KK, Ahmann FR, Dalkin BL, Schiff M (1995) Prostate specific antigen obtained under optimal conditions determines extracapsular adenocarcinoma of the prostate. Br J Urol 75: 21 25
21. Flocks RH (1973) The treatment of stage C prostatic cancer with special reference to combined surgical and radiation therapy. J Urol 109: 461 463
22. Fried PR. Mandell SA (1988) Role of adjuvant radiotherapy following radical prostatectorny for microscopic residual disease. Eur Urol 15: 37 -39
23. Frohmüller H, Theiss M, Wirth MP (1991) Radical prostatectomy for carcinoma of the prostate: long-term follow-up of 115 patients. Eur Urol 19: 279-283
24. Fuks Z, Leibel SA. Wallner K E, Begg CB, Fair WR. Anderson LL, Hilaris BS, Whitmore WF (1991) The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I-implantation. Int J Radiât Oncol Biol Phys 21: 537-547
25. George NJR (1988) Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet ii: 494 497
26. Gerber GS. Thisted RA. Chodak GW, Rukstalis DB, Paulson DE, Middleton AW, Ohori M, Scardino PT. Frohmuller HGW, Schröder FH, Smith JA, Schellhammer PF (1996) Results of radical prostatectorny in men with locally advanced (clinical stage T3) prostate cancer (CaP): multi-institutional analysis (abstract 119). J Urol 155 [Suppl]: 609A
27. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, Scardino PT (1989) Prognostic significance of lymph nodal métastases in prostate cancer. J Urol 142: 332-336
28. Gibbons RP, Correa RJ, Brannen GE, Mason JT (1984) Total prostatectorny for localised prostatic cancer. J Urol 131: 73-76
29. Gibbons RP. Cole BS, Richardson RG. Correa RJ, Brannen GE, Mason JT, Taylor WJ, Hafermann MD (1986) Adjuvant radiotherapy following radical prostatectorny: results and complications. J Urol 135: 65-68
30. Gibbons RP, Correa RJ, Brannen GE, Weissmann RM (1989) Total prostatectorny for clinically localised prostatic cancer: long-term results. J Urol 141: 564-566
31. Graversen PH, Nielsen KT, Gasser TC, Corle DK, Madsen PO (1990) Radical prostatectorny versus primary treatment in stage I and II prostatic cancer. Urology 36: 493-4198
32. Handley R, Carr TW. Travis D, Powell PH, Hall RR (1988) Deferred treatment for prostate cancer. Br J Urol 62: 249 253
33. Hanks G, Krall JM, Pilepich MV, Asbell SO, Perez CA, Rubin P (1992) Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification. Int J Radiât Oncol Biol Phys 23: 293-298
34. Hawkins CA, Bergstralh EJ. Lieber MM, Zincke H (1995) Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (pT3) prostate cancer after radical retropubic prostatectorny. Urology 46: 356-364
35. Hering F, Rist M, Roth J, Mihatsch M, Rütishauser G (1990) Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectorny? Br J Urol 66: 177-181
36. Jewett HJ (1958) Significance of the palpable prostatic nodule. Bull NY Acad Med 34: 26
37. Jones GW (I992) Prospective conservative management of localised prostate cancer. Cancer 70 [Suppl]: 307-310
38. Kabalin JN, McNeal JE, Johnstone IM, Stamey TA (1995) Serum prostate specific antigen and the biologic progression of prostate cancer. Urology 46: 65-70
39. Lerner SE, Blute ML, Zincke H (1995) Extended experience with radical prostatectorny for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 154: 14471452
40. McSherry SA, Levy F, Schiebler ML, Keefe R, Dent GA, Mohler JL (1991) Preoperative prediction of pathological tumor volume and stage in clinically localised prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 141: 85-89
41. Mettlin C. Murphy GP, Menck H (1994) Trends in treatment of localised prostate cancer by radical prostatectomy: observations from the Commission on Cancer national cancer database, 1985-1990. Urology 43: 488 492
42. Middleton RG, Smith JA. Melzer RB, Hamilton PE (1986) Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J Urol 136: 422-424
43. Morgan WR, Bergstralh EJ. Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology 41: 113-120
44. Moskovitz B, Nitecki S. Levin DR (1987) Cancer of the prostate: is there a need for aggressive treatment? Urol Int 42: 49 52
45. Mukamel E. deKernion JB. Dorey F, Hannah J (1990) Significance of histological prognostic indicators in patients with carcinoma of the prostate. Br J Urol 65: 46-50
46. Murphy GP. Natarayan N, Pontes JE, Schmilz RL, Smart CR. Schmidt JD. Mettlin C (1982) The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 17: 928
47. Narayan P. Gajendran V, Taylor SP, Tewari A. Presti JC, Leidich R, Lo R, Palmer K, Shinohara K. Spaulding JT (1995) The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 46: 205-212
48. Nativ O, Winkler HZ. "Raz Y, Therneau TM, Farrow CM, Myers RP. Zincke H, Lieber MM (1989) Stage C prostatic adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 64: 911-919
49. Nesbit RM. Plumb RT (1946) Prostatic carcinoma - a follow-up on 765 patients treated prior to endocrine era and comparison of survival rate between these and patients treated with endocrine therapy. Surgery 20: 263
50. Ohori M, Egawa S, Shinohara K, Wheeler TM, Scardino PT (1994) Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localised prostate cancer. Br J Urol 74: 72-79
51. Ohori M, Goad JR. Wheeler TM, Eastham JA, Thompson TC, Scardino PT (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843-1849
52. Olsson CA. Babayan R. DeVere White R (1985) Surgical management of stage B or C prostatic carcinoma: radical surgery versus radiotherapy. Urology 25: 30-35
53. Ouden D van den. Bentvelsen FM, Boevé ER, Schröder FH ( 1993) Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Br J Urol 72: 489-494
54. Ouden D van den, Davidson PJT, Hop W. Schröder FH (1994) Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 151: 646-651
55. Partin AW, Borland RN, Epstein JE, Brendler CB (1993) Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localised prostate cancer with established capsular penetration. J Urol 150: 142-148
56. Partin AW. Yoo J. Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localised prostate cancer. J Urol 150: 110
57. Partin AW, Lee BR. Carmichael M, Walsh PC, Epstein JI (1994) Radical prostatectomy for high grade disease: a réévaluation. J Urol 151: 1583-1586
58. Paulson DF (1994) Impact of radical prostatectomy on the management of clinically localised disease. J Urol 152- 18261830
59. Rannikko S, Salo JO (1990) Radical prostatectomy as treatment of localised prostatic cancer. Scand J Urol Nephrol 24: 103-107
60. Rönström L, Tribukait B, Esposti P (1980) DNA pattern and cytological findings in fine-needle aspirates of untreated prostatic tumors. A flow-cytofluorometric study. Prostate 2: 79-88
61. Schellhammer PF (1988) Radical prostatectomy: patterns of local failure and survival in 67 patients. Urology 31: 191-197
62. Schröder FH, Belt E (1975) Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J Urol 114: 257-260
63. Schröder FH. Hermanek P. Denis L, Fair WR, Gospodarowicz M. Pavone-Macaluso M (1992) The TNM classification of prostate carcinoma. Prostate 4 [Suppl]: 129-138
64. Scott WW, Boyd HL (1969) Combined hormone control, therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Urol 101: 86-92
65. Shevlin BE, Mittal BB. Brand WN, Shetty RM (1989) The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiât Oncol Biol Phys 16: 1425-1430
66. Stein A, deKernion JB, Smith RB, Dorey F. Patel H (1992) Prostate specific antigen levels after radical prostatectomy in patients with organ-confined and locally extensive prostate cancer. J Urol 147: 942-946
67. Stamey TA, McNeal JE (1992) Adenocarcinoma of the prostate. In: Campbell's urology, 6th edn, vol 2. ch 29. Saunders. Philadelphia, pp 1159-1221
68. Tomlinson RL, Currie DP, Boyce WH (1977) Radical prostatectomy: palliation for stage C carcinoma of the prostate. J Urol 117: 85-87
69. UICC (1992) TNM classification of malignant tumours, 4th edn, 2nd revision. Springer, New York Berlin Heidelberg
70. Veterans Administration Cooperative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124: 1011-1017
71. Veterans Administration Cooperative Urological Research Group (1970) Estrogen treatment for cancer of the prostate: early results with three'doses of diethylstilbestrol and placebo. Cancer 26: 257-261
72. Von Flamm J, Kiesswetter H (1987) Die radicale Prostatektomie beim Prostatakarzinom Stadium C. Z Urol Nephrol 80: 185
73. Whitmore WF (1956) Hormone therapy in prostatic cancer. Am J Med 21: 697-701
74. Whitmore WF (1973) The natural history of prostatic cancer. Cancer 32: 1104
75. Whitmore WF, Warner JA, Thompson IM (1991) Expectant management of localised prostatic cancer. Cancer 67: 1091 -1096
76. Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H. Caroll PR (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node métastases before radical prostatectomy. J Urol 153: 993-999
77. Yamada AH. Lieskovsky G, Petrovich Z, Chen S, Groshen S. Skinner DG (1994) Results of radical prostatectomy and adjuvant therapy in the management of locally advanced clinical stage TC prostate cancer. Am J Clin Oncol 17: 277-285
78. Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ (1994) Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease free outcome. Urology 43: 828-833
79. Zincke H, Utz DC. Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199 1205